Redispensing of unused HIV post-exposure prophylaxis for medical students.

作者信息

Bekker Charlotte L, Kalicharan Raween W, Melis Eward J, Gardarsdottir Helga, van den Bemt Bart J F, Bouvy Marcel L, van Maarseveen Erik M, Egberts Antoine C G

机构信息

Department of Pharmacy, Sint Maartenskliniek, Nijmegen, the Netherlands; Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands.

Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands.

出版信息

Travel Med Infect Dis. 2019 May-Jun;29:82-83. doi: 10.1016/j.tmaid.2019.02.005. Epub 2019 Feb 25.

DOI:10.1016/j.tmaid.2019.02.005

PMID:30818013

Abstract

摘要

相似文献

Redispensing of unused HIV post-exposure prophylaxis for medical students.

Travel Med Infect Dis. 2019 May-Jun;29:82-83. doi: 10.1016/j.tmaid.2019.02.005. Epub 2019 Feb 25.

Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine.HIV感染暴露后预防：一项比较洛匹那韦/利托那韦与阿扎那韦分别联合齐多夫定/拉米夫定的临床试验。

Antivir Ther. 2012;17(2):337-46. doi: 10.3851/IMP1955. Epub 2011 Nov 25.

Side effects and tolerability of post-exposure prophylaxis with zidovudine, lamivudine, and lopinavir/ritonavir: a comparative study with HIV/AIDS patients.齐多夫定、拉米夫定和洛匹那韦/利托那韦暴露后预防的副作用和耐受性：一项针对HIV/AIDS患者的比较研究。

Chin Med J (Engl). 2014;127(14):2632-6.

Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.不良事件与艾滋病毒暴露后预防的依从性：加纳阿克拉科勒-布教学医院的一项队列研究

BMC Public Health. 2015 Jun 20;15:573. doi: 10.1186/s12889-015-1928-6.

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults.西班牙艾滋病研究组首选治疗方案以及洛匹那韦/利托那韦联合拉米夫定用于HIV感染成人初始抗逆转录病毒治疗的成本效益分析

Enferm Infecc Microbiol Clin. 2016 Aug-Sep;34(7):427-30. doi: 10.1016/j.eimc.2015.01.018. Epub 2015 Mar 3.

Non-occupational postexposure prophylaxis for HIV: a systematic review.HIV的非职业性暴露后预防：一项系统综述。

Health Technol Assess. 2009 Feb;13(14):iii, ix-x, 1-60. doi: 10.3310/hta13140.

Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.延长洛匹那韦-利托那韦与拉米夫定预暴露预防方案以减少非洲通过母乳喂养传播 HIV-1 至婴儿 50 周：一项随机对照试验。（ANRS 12174）

Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19.

Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection.齐多夫定-拉米夫定与洛匹那韦-利托那韦联合用于HIV感染暴露后预防的耐受性

Clin Infect Dis. 2005 Jan 15;40(2):303-5. doi: 10.1086/426589. Epub 2004 Dec 21.

Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.北美一个主要队列中暴露后预防（PEP）的依从性与HIV血清转化发生率

PLoS One. 2015 Nov 11;10(11):e0142534. doi: 10.1371/journal.pone.0142534. eCollection 2015.

Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.

Arch Intern Med. 1998 Jul 13;158(13):1470-2. doi: 10.1001/archinte.158.13.1470-a.

引用本文的文献

Environmental Outcomes of Reducing Medication Waste by Redispensing Unused Oral Anticancer Drugs.减少重新分配未使用的口服抗癌药物造成的药物浪费对环境的影响。

JAMA Netw Open. 2024 Oct 1;7(10):e2438677. doi: 10.1001/jamanetworkopen.2024.38677.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验